RECRUITINGOBSERVATIONAL
Role of Exosomes in Pancreatic Cancer Progression
About This Trial
The present pilot study is set up with the objective of identifying circulating markers in the biological fluids (blood and urine) of subjects with pancreatic carcinoma and their association with disease stage, to evaluate their potential use as predictive and diagnostic markers for this tumor of difficult early diagnosis and often inauspicious prognosis.
Who May Be Eligible (Plain English)
Who May Qualify:
- People with pancreatic cancer
- 18 years old
- Obtaining willing to sign a consent form.
Who Should NOT Join This Trial:
- Patients who do not need or cannot perform endoscopy with biopsy sampling;
- patients with a previous or active neoplastic pathology, different from pancreatic neoplasia.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion criteria:
* People with pancreatic cancer
* 18 years old
* Obtaining informed consent.
Exclusion criteria:
* Patients who do not need or cannot perform endoscopy with biopsy sampling;
* patients with a previous or active neoplastic pathology, different from pancreatic neoplasia.
Locations (1)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy